Genetic susceptibility of type 2 diabetes mellitus based on AMPK signaling pathway

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100048552

Enrollment

Unknown

Registered

2021-07-10

Start date

2021-07-12

Completion date

Unknown

Last updated

2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus

Interventions

case group:N/A

normal group:N/A

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Case group (1) Aged 20 to 70 years; (2) A random blood glucose >=11.1 mmol/L, accompanied by diabetes symptoms (hyperglycemia caused by hyperglycemia, polydipsia, polyuria, weight loss, pruritus, blurred vision, etc.), or without diabetes symptoms, fasting blood glucose >=7 mmol/L, or 2 hours after glucose loading, blood glucose>=11.1 mmol/L; (3) No other serious diseases such as cardiovascular and cerebrovascular diseases, malignant tumors, chronic liver and kidney diseases. 2.Control group (1) Aged 20 to 70 years; (2) no family history of diabetes; (3) The results of medical history, physical examination, blood glucose test and other biochemical tests were normal.

Exclusion criteria

Exclusion criteria: Other serious diseases such as cardiovascular and cerebrovascular diseases, malignant tumors, chronic liver and kidney diseases.

Design outcomes

Primary

Measure	Time frame
blood glucose;singlenucleotidepolymorphism typing;Deoxyribonucleic acid methylation;	—

Countries

China

Contacts

Public ContactDing Yuanlin

Guangdong Medical University

gdmcsbd@163.com+86 769 22896366

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026